Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph K Han

Showing results (101-110 of 135) with videos related to

Pageof 14
Sort By:
The Lancet. Respiratory Medicine|April 19, 2021
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trialJoseph K Han, Claus Bachert, Wytske Fokkens, et al.
American Journal of Rhinology & Allergy|May 24, 2019
In-office Placement of Mometasone Furoate Sinus Implants for Recurrent Nasal Polyps: A Pooled AnalysisJ Pablo Stolovitzky, Robert C Kern, Joseph K Han, et al.
The Journal of Allergy and Clinical Immunology|September 16, 2021
Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension studyPhilippe Gevaert, Rebecca Saenz, Jonathan Corren, et al.
Allergy|August 30, 2021
Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trialsJoaquim Mullol, Tanya M Laidlaw, Claus Bachert, et al.
Journal of Asthma and Allergy|September 11, 2023
Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATORTanya M Laidlaw, Andrew Menzies-Gow, Scott Caveney, et al.
Allergy|August 17, 2021
From DREAM to REALITI-A and beyond: Mepolizumab for the treatment of eosinophil-driven diseasesIan D Pavord, Elisabeth H Bel, Arnaud Bourdin, et al.
British Journal of Clinical Pharmacology|May 8, 2024
Pharmacokinetics/pharmacodynamics of benralizumab in chronic rhinosinusitis with nasal polyps: Phase III, randomized, placebo-controlled OSTRO trialClaire Emson, Joseph K Han, Claire Hopkins, et al.
International Forum of Allergy & Rhinology|October 1, 2014
RESOLVE: a randomized, controlled, blinded study of bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposisJoseph K Han, Keith D Forwith, Timothy L Smith, et al.
International Forum of Allergy & Rhinology|February 21, 2021
Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polypsClaire Hopkins, Martin Wagenmann, Claus Bachert, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 29, 2024
Mild and symptom-free months in patients with chronic rhinosinusitis with nasal polyps treated with dupilumabClaus Bachert, Asif H Khan, Claire Hopkins, et al.
Pageof 14

Showing results (101-110 of 135) with videos related to

Sort By:
Pageof 14
The Lancet. Respiratory Medicine|April 19, 2021
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trialJoseph K Han, Claus Bachert, Wytske Fokkens, et al.
American Journal of Rhinology & Allergy|May 24, 2019
In-office Placement of Mometasone Furoate Sinus Implants for Recurrent Nasal Polyps: A Pooled AnalysisJ Pablo Stolovitzky, Robert C Kern, Joseph K Han, et al.
The Journal of Allergy and Clinical Immunology|September 16, 2021
Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension studyPhilippe Gevaert, Rebecca Saenz, Jonathan Corren, et al.
Allergy|August 30, 2021
Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trialsJoaquim Mullol, Tanya M Laidlaw, Claus Bachert, et al.
Journal of Asthma and Allergy|September 11, 2023
Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATORTanya M Laidlaw, Andrew Menzies-Gow, Scott Caveney, et al.
Allergy|August 17, 2021
From DREAM to REALITI-A and beyond: Mepolizumab for the treatment of eosinophil-driven diseasesIan D Pavord, Elisabeth H Bel, Arnaud Bourdin, et al.
British Journal of Clinical Pharmacology|May 8, 2024
Pharmacokinetics/pharmacodynamics of benralizumab in chronic rhinosinusitis with nasal polyps: Phase III, randomized, placebo-controlled OSTRO trialClaire Emson, Joseph K Han, Claire Hopkins, et al.
International Forum of Allergy & Rhinology|October 1, 2014
RESOLVE: a randomized, controlled, blinded study of bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposisJoseph K Han, Keith D Forwith, Timothy L Smith, et al.
International Forum of Allergy & Rhinology|February 21, 2021
Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polypsClaire Hopkins, Martin Wagenmann, Claus Bachert, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 29, 2024
Mild and symptom-free months in patients with chronic rhinosinusitis with nasal polyps treated with dupilumabClaus Bachert, Asif H Khan, Claire Hopkins, et al.
Pageof 14